Ple131-lacZ (Positive)*
|
|
Other constructs for this MiniPromoter: NONE |
|
Other constructs for this Gene: Ple129-lacZ (Positive) |
|
|
 |  |  |  |  | 7.9 weeks, N1, Female (entire series) | 7.9 weeks, N1, Female (entire series) | 7.9 weeks, N1, Female (entire series) | 7.9 weeks, N1, Female (entire series) | 7.9 weeks, N1, Female (entire series) |
|
|
|
|
|
Ple131-lacZ Description:
This Ple131 promoter construct is derived from the promoter region of the Antigen KI-67 (MKI67) gene. The Pleiades Promoter Project created a 3088 bp MiniPromoter derived from two upstream and one downstream putative regulatory subregions along with a section of the promoter and introduced it into the multiple cloning site (MCS) of Pleiades expression vector pEMS1313 (LacZ reporter flanked by full frt sites (WT and F5 mutant)) to make plasmid pEMS1602 with Ple131 driving lacZ. The Ple131-lacZ (pEMS1602) was introduced by homologous recombination as single copy insertion into the Hprt1b-m3 locus in the X Chromosome of mouse embryonic stem cells (ESCs) mEMS1202. The resulting PCR validated four ESC lines, mEMS4655, mEMS4657, mEMS4658, and mEMS4659. Chimeras were generated using mEMS4655.
Note: Promoterless negative controls (pEMS1302, pEMS1306, pEMS1313)
have been generated, as well as CAG positive controls (pEMS1157,
pEMS1277 & pEMS1488).
|
|
|
Ple131-lacZ Expression Pattern:
|
|
|
Ple131 MiniPromoter Resources:
|
|
|
|
|
|
|
|
|
|
* The Ple131 MiniPromoter (Patent Pending) is proprietary - any commercial
use of the MiniPromoter will require a direct license from The University of British
Columbia. Please direct all licensing inquiries to Sue Kingsley, MBA, PhD,
sue@biopharmasolutions.com Office:
604-408-4310
|
|